Business Continuity And Disaster Recovery World Tue, 09 Aug 2022 07:00:00 +0000 en-US hourly 1 Business Continuity And Disaster Recovery World 32 32 TNG Receives A$200 Million Contingent Debt Facility for Mt Peake Project Tue, 09 Aug 2022 07:00:00 +0000

One of Australia’s leading mineral and resource processing technology companies, TNG Limited (ASX: TNG) has secured a major component of multi-source global financing for its Mount Peake Vanadium-Titanium-Iron project in the Northern Territory.

In the latest development, TNG received conditional debt financing of A$200 million from the Korea Trade Insurance Corporation (K-Sure), which is South Korea’s official export credit agency under the supervision of the Ministry of Trade, Industry and Energy. This debt financing is for TNG’s flagship project, Mount Peake, pursuant to the terms of a conditional letter of support.

Image Source: © 2022 Kalkine Media ®, Data Source: Company Announcement

K-SURE Letter of Support Details

K-SURE’s letter of support follows the Memorandum of Understanding signed between Australia and the Republic of Korea in December 2021. The Memorandum of Understanding was based on cooperation in critical mineral supply chains.

Image Source: © 2022 Kalkine Media ®, Data Source: Company Announcement

TNGs multi-pronged global funding strategy

To date, conditional interest funding of up to A$800 million has been provided to TNG for the said project through numerous letters of support/conditional interest from various funding sources supported by Australian governments. , Korean and German.

In addition, seven Australian and international commercial and investment banks have expressed interest in providing capital for the commercial debt component.

TNG believes that its financial strategy for the Mount Peake Project is firmly on track with continued financial support and substantial interest from government-backed funding sources as well as the commercial debt market.

Which alternative funds performed well in the market rout? Mon, 08 Aug 2022 18:30:33 +0000

There were also outstanding performances among liquid alts, some leveraged and inverse products taking advantage of the market environment, and other defensive funds performing as expected during a large sell-off.

According to figures provided by Fundata, 10 Canadian alternative mutual funds posted double-digit returns for the first half of the year, and seven others posted returns between 5% and 10%. (This count does not include passive inverse and leveraged products, some of which have done extremely well on energy indices or with inverse exposure to broad indices.)

Five of the top performers came from Horizons ETFs Management (Canada) Inc., with the company’s BetaPro Inverse Bitcoin ETF rising 91.5% in late June, per Fundata, as the price of Bitcoin crashed. (The fund fell 25% last month and was up 42% for the year to July 31, according to Horizons.)

The maker’s natural gas and crude oil ETFs also rose more than 36% in the first half, according to Fundata.

However, these products are not long-term investments to include in most client portfolios.

“The problem with a lot of alternatives is that they tend to be binary,” said Mark Noble, executive vice president of ETF strategy at Horizons. Some funds have long or short positions, while others have full exposure to a volatile sector.

“While the reverse of Bitcoin has been an incredibly successful strategy, the risk factor behind it is off the charts,” Noble said, adding that pure natural gas and petroleum products are also extremely volatile.

Another fund, the Horizons ReSolve Adaptive Asset Allocation ETF, performed well in the first half but is designed to generate returns in all market conditions. The fund returned 7.2% through the end of June, according to Fundata.

The fund is more diversified than standard stock-bond or long-short stock strategies, Noble said, as certain triggers prompt it to sell bonds, for example, or overweight commodities.

“These things allowed him to generate positive returns in otherwise negative market conditions for stocks and bonds,” he said.

Another fund that performed well in the first half was the AGFiQ US Market Neutral Anti-Beta CAD-Hedged ETF, which returned 22% through June, according to Fundata. The fund is designed to protect investors against major declines in US equities, as happened in the first half of this year.

The fund invests in long positions in low-beta US stocks and sells short high-beta stocks, such as long-duration growth stocks that are most affected by rising interest rates.

“It’s very helpful for investors because there are very consistent market environments where the fund will do well,” said Bill DeRoche, chief investment officer at AGF Investments LLC and head of AGFiQ Alternative Strategies. “And there are other environments where it will work poorly.”

With bond performance as lackluster as the first half and traditional funds 60-40 killed, DeRoche said, the ETF has proven to be a particularly effective risk-mitigation tool. It could continue to replace fixed income if rates continue to rise, he said.

Stocks and bonds have rebounded since late June, but DeRoche said he expects more volatility before returning to a risk environment. Interest rates still need to rise to keep inflation under control, but many investors have started to price in a recession and lower interest rates.

“I think everyone is missing an intermediate step,” he said.

However, DeRoche said investors will want to reduce exposure to the fund when rate cuts occur. “When we are at risk, due to negative beta, you would expect the fund to underperform as we have seen historically.”

Other top performing liquid alternative funds in the first half of the year included the Fidelity Global Value Long-Short Fund, which seeks to exploit the misvaluation of value stocks and rose 42.2%, per Fundata, and the d Arrow Capital Inc.’s diversified global investment Wavefront (Series A), up 28.9%.

Down Between 15% and 53%: 3 Top Dividend Aristocrats Too Cheap to Ignore Sun, 07 Aug 2022 10:41:15 +0000

JThe stock market sell-off has been a good time to find new businesses that can serve as quality long-term investments and a source of passive income. A good place to start is to browse the list of Dividend Aristocrats – who are S&P500 companies that have paid and increased their dividends for at least 25 consecutive years.

Stanley Black & Decker (NYSE: SWK), Atmospheric and chemical products (NYSE: ODA)and Chevron (NYSE: CVX) behave very differently in the current market environment, which is reflected in their share price. However, each company has a proven track record of growing its dividend, even in tough times. Moreover, the very contrasting performances of these three companies give a good reading of the health of the energy and industry sectors. Here’s what makes each stock a great buy now.

Image source: Getty Images.

Value investors will watch this industrial tools and products company carefully

Lee Samaha (Stanley Black & Decker): The hardware and tools company recently released the kind of earnings report every investor dreads. Forecasts have been reduced, business conditions are weakening as end demand declines, inventory needs to be reduced, cost headwinds continue, and the company is restructuring to reduce costs.

Management started the year heading for full-year adjusted earnings per share of $12 to $12.50. But after slashing its forecast in the second quarter, it now expects just $5-6. So, it’s not hard to see why the stock is down more than 50% in 2022 as I write. That’s probably not how new CEO Don Allan envisioned his first earnings call, but as a former CFO, he’ll know well what the company needs to do.

That said, there’s not much management can do about weak consumer spending hitting home tool sales or unfavorable weather conditions causing sluggish outdoor equipment sales. However, he can adapt to these problems, and that is precisely what he does. The cost reduction plans aim to reduce costs by $2 billion over three years. Meanwhile, management estimates it can achieve around $7.25 in earnings in 2023, a figure that would put Stanley at less than 13 times its 2023 earnings. With more cost reductions and hopefully a better trading environment in the future, the company will see better days. However, be aware that it will still face challenges to reduce inventory while maintaining satisfactory prices in 2022.

This chemical stalwart has been paying dividends for decades, and it shows few signs of slowing down

Scott Levine (Aviation Products and Chemicals): With the S&P 500 plunging more than 14% year-to-date, investors haven’t had to look far to find quality stocks for sale. But to find superior dividend stocks that are also trading at a discount? It’s an exciting opportunity for long-term investors – and that’s exactly what’s available now with the shares of Air Products & Chemicals, a leading supplier of industrial gases, and its forward dividend yield of 2. 6%. Year-to-date, shares of Air Products have fallen about 20%, creating a great buying opportunity.

Call it what you will — a summer sale or a back-to-school bargain — the opportunity to grab Air Products inventory at a discount is visible in more ways than one. The stock is currently trading at 21.2 times forward earnings, which is a bargain compared to its five-year average forward earnings multiple of 24.5.

Skeptics wondering what caused the stock to drop in 2022 won’t find anything wrong with the company that would stop them from adding it to their portfolios. The stock’s poor performance is no doubt the result of analysts’ reduction in price targets and fears of an economic slowdown. Analyst price targets should always be taken with a grain of salt since Wall Street often has shorter investment horizons than the multi-year holding periods we favor. When it comes to an economic downturn, Air Products could very well see its business affected, but its 40-year tenure as a dividend aristocrat suggests that management has handled downturns deftly before – and should be able to weather it as well. this one.

With its industry-leading position as a supplier of industrial gases like argon, xenon, oxygen and nitrogen – among other transactions – Air Products is well positioned to maintain its dividend, while its focus to growth opportunities, such as hydrogen, suggests that dividend growth is also a strong possibility.

A disciplined oil major with an attractive dividend

Daniel Foelber (chevron): Chevron may be down just 15% from its 52-week high. But the large integrated oil and gas company remains a good value for investors looking for a growing dividend from one of the most efficient and diversified oil and gas companies in the market.

SWK Chart

SWK data by YCharts

Chevron posted record quarterly earnings of $11.6 billion or $5.95 per diluted share for the second quarter of 2022 and net income of $17.9 billion in the six months ended June 30 2022. For context, it generated more net profit in the first half of 2022 than in any full calendar year in the past five years.

Using traditional valuation metrics like price-to-earnings ratio on cyclical stocks like Chevron can be unnecessary because earnings vary with the market cycle. Enter Chevron, which was the best performing stock in the Dow Jones Industrial Average in 2022 and has a P/E of just 10.2 even after its share price climbed.

On the contrary, what makes Chevron a good business is that it can limit losses during downturns and generate outsized profits during boom times while supporting a growing dividend. In contrast, many oil and gas companies were forced to cut their dividends in 2020 and suffered significant losses.

The past two to three years provide the perfect stress test that investors can use to gauge performance and management decisions under different market conditions. Chevron is doing very well because it limited losses in 2020, was able to buy assets at low prices and grow its high-margin Permian Basin portfolio, increased its dividend, has a rock-solid balance sheet and continues to show resilience. Disciplined Investment Even During Favorable Conditions.

For example, its Permian production was 15% higher in the second quarter of 2022 than a year ago, but international production was down 13% and US production was up only 3%. The company is constantly looking for ways to divert capital to its best performing assets without overinvesting and leaving itself vulnerable to the next downturn. With a dividend yield of 3.6% and an asset portfolio that looks stronger than ever, Chevron is a dividend aristocrat built to last.

10 stocks we like better than Stanley Black & Decker
When our award-winning team of analysts have stock advice, it can pay to listen. After all, the newsletter they’ve been putting out for over a decade, Motley Fool Equity Advisortripled the market.*

They just revealed what they think are the ten best stocks investors can buy right now…and Stanley Black & Decker wasn’t one of them! That’s right – they think these 10 stocks are even better buys.

View all 10 stocks

* Portfolio Advisor Returns as of July 27, 2022

Daniel Foelber has no position in any of the stocks mentioned. Lee Samaha has no position in the stocks mentioned. Scott Levine has no position in the stocks mentioned. The Motley Fool has no position in the stocks mentioned. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Liquid Cooled Servers Market Size, Share, Analysis by Type, Application, Key Players, Growth Trend and Regional Development Forecast to 2028 Sat, 06 Aug 2022 18:18:06 +0000

Intelligence Market Report Publish a new research report on “Liquid Cooled Servers Market 2022 Global Analysis by Size, Share, Trend, Opportunities and Regional Growth, Forecast 2028”

This press release was originally distributed by SBWire

London, UK – (SBWIRE) – 08/06/2022 – Liquid Cooled Server Market Scope and Overview

SWOT Analysis, Poster’s Five Force Analysis, Player Positioning Analysis, PESTEL Analysis, Value Chain Analysis and Market Share Analysis have been used to collect, analyze and to evaluate the research study data on the Liquid Cooled Servers Market. The study examines the scope and volume of the global market at regional and country level. Market research examines historical data as well as potential variables to create a projection of the market in a global context.

Get Free Sample of Liquid Cooled Servers Market @

Leading companies reviewed in the Liquid Cooled Servers Market‎ report are:

Ali Baba
Inspur Group

Researchers can therefore use this research technique to assess the market in light of a range of variables, including consumer preferences, financial investments, government regulations, distribution channels, and brand loyalty. The Liquid Cooled Servers Market study also includes in-depth and qualitative analysis of industry projections, verifiable statistics, comparative data, market valuation and market size volume.

Segmentation analysis

The liquid cooled server market is categorized in the market study on the basis of type, application, end-use industry, and geography. All industry sectors are researched and evaluated based on recent and anticipated market trends. The analysis examines the top performing sub-categories and projects the growth rate of one of the key market sectors.

Liquid Cooled Servers Market Segmentation As Follows:

Segmentation by type:

Segmentation by applications:
Data center

Segmented by region/country
North America
Asia Other

Make an Inquiry on Liquid Cooled Servers Market @

Regional coverage

The Global Liquid Cooled Servers Market study takes a close look at the industry worldwide. The market is mainly made up of North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. While determining the top global market share by region, revenue, sales, shares, recent advancements, innovations, and growth rates are all taken into consideration. This regional analysis topic examines the market from the perspective of multiple nations and regions.

Competitive Perspectives

All major market players are profiled in the report along with their most important products and services. Recent mergers and acquisitions between these large companies are also examined in the research. The major manufacturers and distributors in each of the major geographies of the world are also listed in the Liquid Cooled Servers Market research report. The results of the study have led some companies in the sector to expand their geographical and distribution reach.

Main Highlights of the Liquid Cooled Servers Market Report

– The research report gives current information about the industry and analyzes all the recent changes in the market.
– The report assesses the microeconomic and macroeconomic effects in the global market.
– The analysis also discusses key market drivers, restraints, trends, and opportunities, and their current and future effects.
– In-depth analysis of the industry competitive landscape along with comprehensive vendor data
– Information on industry dynamics, market insights and current and future market trends are also included in the market research.

Table of Contents – Analysis of Key Points

Chapter 1. Executive Summary

Chapter 2. Global Market Definition and Scope

Chapter 3. Global Market Dynamics

Chapter 4. Global Liquid Cooled Servers Market Analysis

Chapter 5. Global Liquid Cooled Servers Market, By Type

Chapter 6. Global Liquid Cooled Servers Market, By Application

Chapter 7. Global Liquid Cooled Servers Market, Regional Analysis

Chapter 8. Competitive Intelligence

Chapter 9. Key Company Analysis

Chapter 10. Research Process


Buy Single User PDF @

For more information on this press release, visit: -growth-trend-and-regional-development-forecasts-until-2028-1361804.htm

Startup Mantra: Making cancer detection more accessible Sat, 06 Aug 2022 12:59:50 +0000

In May 2022, the Indian Council for Medical Research published a report on the burden of cancers in India. It is expected that the number of Indians suffering from cancer will increase to around 3 crore in 2025. Continuous monitoring of cancer status (every 3-4 months) will ensure that any recurrence of cancer is detected early enough for the patient seeks effective treatment, however, most people find it unaffordable to undergo such tests.

Actorius Innovations and Research Pvt Ltd (AIR), a Pune-based research and development company, has created a new biomaterial with critical applications in life sciences, drug delivery and medical diagnostics.

Founded in 2013 by Jayant Khandare and Aravindan Vasudevan, the company launched its first product, the “OncoDiscover liquid biopsy test”, a minimally invasive test that can be performed multiple times requiring a blood volume of 1.5ml. This test is an excellent therapeutic monitoring tool and can be carried out at several times, for example during the initial check-up, before the operation, after the operation, after the chemotherapy and during the follow-up. Since circulating tumor cells (CTCs) present in the patient’s blood are enumerated (counted) by this test, it becomes a quantitative reference for monitoring disease progression and treatment efficacy.

At first…

Khandare, Managing Director and Scientific Director of the company, obtained his bachelor’s and master’s degrees in pharmacy. Khandare obtained a PhD (Polymer Chemistry) in Chemical Engineering from the National Chemical Laboratory, Pune in 2003. He has worked extensively on targeted nanotechnology. polymeric drug delivery systems for cancer. The company’s co-founder, Vasudevan, holds a master’s degree in chemistry and a certificate in business studies (marketing). Vasudevan has worked as a scientist in the pharmaceutical and drug discovery industry. The duo had met at marathon events hosted by the company they previously worked with.

Khandare says, “The Department of Biotechnology (DBT) promotes ‘high risk’ scientific innovation in India. Innovation can be simple, frugal or complex, but we miss it completely. We have the best scientists, but they are more committed to academics and fundamentals than to products and innovations. Neither scientists nor venture capitalists want to take risks in science startups and as a result there are very few success stories in healthcare innovation in India.

“For example, we haven’t discovered any drugs or done anything innovative in the diagnosis of cancer. We import medical devices worth over $10 billion per year to India. We have a lot of unmet needs and challenges, but we didn’t have medical rules or a network and ecosystem for startups to meet them. Similarly, India has very good doctors but due to high patient load, they are not inclined to do research activities. I was working at the National Chemical Laboratory (NCL) and after finishing my PhD I went to the United States. While deliberating on India’s innovation ecosystem, I decided to return to India and prove that innovative medical devices and products can be developed locally,” he added.

Early detection and monitoring

In India, a patient goes to a doctor or hospital, is diagnosed with cancer and further treatment like chemotherapy, and radiation therapy is performed. According to Khandare, early detection, treatment and patient management and monitoring are three important aspects, which we are good at treating patients.

“There are a lot of misconceptions about detecting cancer early using genetic testing. Doctors cannot treat these patients unless a PET scan (positron emission tomography) and biopsy are performed. Early detections are made possible by science-based companies, but clinicians have no solution for this and so we need to make early detection more ‘realistic’,” he said.

“In terms of surveillance, we are lagging behind because we do not follow up patients once the disease is considered ‘cured’. There are 50 lakh cancer survivors in India. Another statistic states that 90% of cancer patients succumb to the disease due to undetected early metastasis (spread of loosely bound cancer cells from primary organs to a distant organ). This means that they have less chance of survival if they are not monitored regularly. A PET/MRI (about 8-10mm) often misses the presence and spread of cancer cells (10-30 microns in size) in the body. Being PET/MRI negative does not mean the patient is disease free,” Khandare said.

Technology development

Since 2004, a cancer diagnostic blood test in the United States has been used to detect capture and enumerate circulating tumor cells (CTCs) in a blood volume of 7.5 ml, with a 10-day delay. It has also been used to predict the survival period of patients.

“The test in the United States was priced at 1.5 lakh and was unaffordable for Indians. CTC technology makes it possible to avoid surgery to remove tissue. But for that, we need advanced biomaterials, antibodies, machines, AI systems, computing power, etc. We started working on this technology to develop our native biomaterial. For the first two years, we worked on materials science at the NCL Venture Center and also got a scholarship from 40 lakh of DBT. But we had to wait till 2019 for indigenous technology and device to develop new medical device rules 2017. This initiative was actively supported by FDA Maharashtra. Dr Harsha Vardhan, former Union Health Minister, initiated the test in India,” Khandare informed.


The OncoDiscover liquid biopsy test is a patented and locally developed in vitro diagnostic test that has obtained approval from the Drug Controller General of India (DCGI) for commercialization in India. This test is a highly specific and sensitive test that can detect, capture and enumerate circulating tumor cells in a very small volume of blood.

Elaborating further on this technology, Khandare said, “We are processing a 1.5ml blood sample. Using advanced biomaterials, we identify cancer cells from over a billion cells present in this sample. We had obtained ethical clearance from Tata Memorial Hospital in Mumbai to conduct clinical trials. The required biomaterial and specificity are very high for this type of test and we managed to achieve this.

Future plans

Sharing his future plans, Khandare said: “Currently valued at 110 crore, we are now setting up our sales and marketing team for OncoDiscover. Besides OncoDiscover, we are working on four other tests for cancer cells. Of these, the first test will be launched in December 2022, which will allow oncologists to decide immuno-oncology treatment decisions that can prolong and save a patient’s life. We also work with some US companies and plan to open our lab there. Our ultimate goal is to put all 50,000 cancer patients under surveillance and for this we are trying to reduce the cost of testing by a third.

Companies Shift Profits to High Net Worth Investors Tax-Free – A Share Buyback Tax Would Change That – ITEP Fri, 05 Aug 2022 18:15:43 +0000

Last night, Senate Democrats announced agreement on the Cut Inflation Act which, among other changes to a previous version of the bill, would apply a 1% tax on corporations buying back their own stock. This proposal was included in the Build Back Better Act passed by the House last year and was estimated at the time to be worth $124 billion over 10 years (see an earlier ITEP analysis of this proposal here). This measure would ensure that income transferred from corporations to wealthy shareholders does not continue to escape tax.

Share buybacks, like dividends, are a tool that companies use to give income to their shareholders because they have decided that the money has more value outside the company rather than being reinvested. in the business. Where dividends achieve this by giving money directly to their shareholders, share buybacks work indirectly. When a company reduces the number of its shares outstanding in the market through a stock buyback initiative, it increases the value per share for the remaining shareholders. (As explained in the previous ITEP analysis, the relationship between stock buybacks and shareholder value is not always one-to-one, but it is almost always positive.)

Share buybacks, however, are not taxed like dividends, creating a clear investor preference for share buyback initiatives over cash dividends. Dividends are taxed as they are distributed, and for most investors and stocks they are taxed at a rate of 15-20% (15-30% for foreign investors). However, share redemptions do not create an immediate taxable event, but rather increase the taxable capital gains investors will pay when they sell those shares.

The problem is that these capital gains are often never taxed at all. If the owner of the shares keeps his shares, he will not be taxed, because his gains are considered “unrealized”. Whether or not their earnings are realized, their ability to buy things – what economists and normal people would call Income-increased. And if they pass on their equity holdings to their heirs, the capital gains will never be taxed at all, benefiting from the base-increasing rule.

If an investor benefiting from a repurchase of shares of a company does not reside in the United States, they may not pay anything on their capital gains. Foreign investors (who own about 40% of the shares of US corporations) are not subject to the federal personal income tax that would apply to their realized gains if they lived in the United States. The federal government, however, taxes dividends paid to foreign investors at rates ranging from 15 to 30%. If the capital gains rate in their home country is very low, there can be considerable tax savings for share buybacks compared to dividend distributions.

The Senate Democrats’ proposal would apply a 1% excise tax to corporations when they buy their own stock. While this would certainly mark progress in ensuring that wealthy investors pay something on the appreciation of their assets, it is not clear to what extent this would put the tax treatment (and therefore investors’ preferences) for dividends and share buybacks on an equal footing.

The 1% rate is obviously much lower than the rate for most dividends. As explained in the ITEP analysis of the proposal included in the Build Back Better Act, the stock redemption tax should be closer to 12% to achieve tax parity with the dividend tax in terms of revenue collection .

On the other hand, the stock redemption tax is mechanically quite different from the dividend tax, decreasing the after-tax income of the company rather than the after-tax income of its shareholders. About 35% of US corporate stock owners are non-taxable accounts, mostly retirement accounts. These shareholders are not affected by dividend taxes, but would pay some of the tax on share redemptions through the value of their shares. These shareholders would unambiguously prefer dividend distributions to buyback programs with this excise tax in place.

Congress should pass this provision now. Corporations are increasingly using stock buyback initiatives to benefit their shareholders while avoiding the income taxes that would apply to functionally equivalent dividend distributions. In the first year following the Republicans’ tax reform bill of 2017, corporations repurchased a record $1 trillion of their own stock. This provision by Senate Democrats would at the very least hamper the ability of companies to engage in completely tax-free stock buybacks. And at best, it will change investor preferences enough to curb the meteoric rise in share buybacks.

The alternative protein market should reach a valuation Fri, 05 Aug 2022 10:30:00 +0000

NEWARK, Del, Aug. 05, 2022 (GLOBE NEWSWIRE) — A recently released study by the IMF projects that the global protein alternative market will grow at a CAGR of 21% from 2022 to 2032. By the end of the forecast period , the alternative protein market is expected to generate a market value of US$73.44 billion. Alternative proteins are gaining prominence in the livestock industry and the food and beverage industry due to the nutrition they provide. Innovations and launches of different proteins increase the sales of alternative proteins.

From 2016 to 2021, the global pet snacks and treats market recorded a CAGR of 14% accumulating a market value of US$61 billion in 2021. The COVID-19 pandemic has played a key role in increasing the importance of boosting immunity. So, most people have invested in organic and clean proteins to stay healthy. In addition, the demand to meet the dietary needs of animals increases the demand for alternative proteins.

Request a sample @

North America, Asia-Pacific, and Europe are major contributors to the alternative protein market for different reasons. Most people suffer from lactose intolerance or food allergies. Thus, consumers are investing in alternative proteins. International players and start-ups are launching different protein products to cater to a wider consumer base.

Key insights from market research

  • By source, microbial protein is expected to possess 40% market share for alternative protein market during the forecast period 2022-2032.
  • By application, animal feed is expected to provide 55% market share to alternative proteins
  • North America is expected to hold 40% of the alternative protein market share
  • Asia-Pacific expected to gain 18% market share for alternative proteins
  • Europe is expected to own 25% market share for the alternative protein market over the assessment period.

“Alternative protein manufacturers focus on innovation and sustainability. This has led to the production of cleaner and nutritious proteins, thus increasing the sales of these. » says an IMF analyst.

Request a brochure @

Market competition

The major players in the global alternative protein industry are Cargill Incorporation, Royal DSM NV, AMCO Proteins, Puris, Axiom Foods, Darling Ingredients, Innovafeed, Lallemand Inc, Hamlet Protein, Archer Daniel Midland Company, AB Mauri, Soja Protein, Ingredion , Ynsect, Angel Yeast and Calysta Inc.

  • Cargill Incorporation, a key player introduced pea protein in the Asian market. Pea protein includes non-GMO characteristics and is low allergenic. The protein is very versatile and can be used in different food preparations.
  • Royal DSM NV has launched CanolaPRO, a vegetable protein source made from canola (rapeseed). The protein is gluten-free, dairy-free, non-GMO and provides mouth-feel texture.

More information available

FMI, in its new offering, presents an unbiased analysis of the global protein alternatives market, showcasing historical analysis from 2016 to 2021 and forecast statistics for the period 2022-2032.

The study reveals critical information on the basis of by source (insect-based, microbial-based, plant-based, other) by application (food and beverage, cattle, aquaculture, animal feed, feed companion, equine, other) across five major regions (North America, Latin America, Europe, Asia-Pacific and Middle East & Africa).

Ask an analyst @

Key segments profiled in the Protein Alternatives Market industry investigation
Alternative Proteins Market by Source:

  • Alternative protein from insects
  • Microbial based alternative protein
    • bacteria
    • Yeast
    • Algae
    • Mushrooms
    • Others
  • Plant-Based Alternative Protein
    • Soy Protein Isolates
    • Soy Protein Concentrates
    • Fermented soy protein
    • duckweed protein
    • Others
  • Other Alternative Protein Sources

Alternative Proteins Market by Application:

  • Alternative protein for food and beverages
  • Alternative protein for cattle
  • Alternative protein for aquaculture
  • Alternative Protein for Animal Feed
  • Alternative protein for pet food
  • Alternative Protein for Equine
  • Alternative protein for other applications

1. Summary

1.1. Global market overview

1.2. Demand Side Trends

1.3. Supply-side trends

1.4. MFI analysis and recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Introduction and market definition

3. Market Context and Basic Data Points

3.1. Need of the hour for industries

3.2. Alternative Protein – Strategic Priorities

3.3. Life cycle stage

3.4. Importance of technology

3.5. Alternative Protein Use Cases

3.6. Prediction factors: relevance and impact

3.7. Investment Feasibility Matrix

3.8. PESTLE Analysis

3.9. Porter’s Five Forces Analysis

3.10. Market dynamics

3.10.1. Drivers

3.10.2. Constraints

3.10.3. Opportunity analysis

3.10.4. Orientation

4. Global Protein Alternatives Market Demand (US$ min) Analysis 2017-2021 and forecast, 2022-2032

4.1. Historical Market Value Analysis (USD Million), 2017-2021

4.2. Current and Future Market Value Projections (USD Million), 2022-2032

4.2.1. Analysis of annual growth trends

4.2.2. Analysis of opportunities in absolute dollars

Contents continued..!

Take a look at Food and drink Research reports related to the field:

Pea Protein Ingredients Market Size: Pea Protein Ingredients market sales are estimated to reach US$1.25 billion in 2021. According to Future Market Insights (IMF), the global market value is expected to reach 2. US$5 billion by 2031.

Soy Protein Ingredients Market Trends: Soy protein ingredients often serve as an alternative to animal protein in the global market, due to their organic nature.

Pea Protein Market Outlook: Pea protein market revenue totaled US$3.2 billion in 2021, according to Future Market Insights (IMF). With a CAGR of 14.2% for 2021-31, the market is expected to reach US$12.31 billion by 2031.

Dry Mixes Market Forecast: The global dry mixes market is expected to be valued at USD 8,700.0 million in 2022, and is expected to grow at a CAGR of 5.9% to be valued at USD 15,434.0 million Americans from 2022 to 2032.

Melaleuca alternifolia Market Share: The Melaleuca alternifolia market is expected to grow at a CAGR of 7.4% through 2032 and is expected to reach a value of US$48 million in 2022. By 2032, the market size of Melaleuca alternifolia alternifolia is expected to increase to US$. 98 million.

Catalase Market Type: The global catalase market is expected to be valued at USD 387.4 million in 2022, and is expected to grow at a CAGR of 2.9% to be valued at USD 516.6 million. 2022 to 2032.

Squash Market Demand: The global squash market is expected to be valued at US$1,510.6 million by 2032, from US$1,027.6 million in 2022, growing at a CAGR of 4.7 % over the forecast period.

Cassia Seed Extract Market Analysis: The global demand for Cassia Seed Extract is expected to be valued at US$395.7 million in 2022, and is expected to grow at a CAGR of 6.2% to be valued at 641 .0 million US dollars from 2022 to 2032.

Liquid Dietary Supplements Market Technology: The global liquid dietary supplements market is expected to reach a value of US$5,918.2 million in 2022 and to reach US$9,732.3 million by 2032.

L-Lysine Hydrochloride (HCL) Market Growth: Global demand for L-lysine hydrochloride (HCL) is expected to be valued at US$240.6 million in 2022, and is expected to grow at a CAGR of 4.2% to be valued at US$341.7 million from 2022 to 2032.

Download a free copy of the Future Market Insights white paper in collaboration with PBFIA, on the plant-based market that highlights potential opportunities and investments being made in the global plant-based market

Subscriptionut Future Market Insights (IMF)

Future Market Outlook (ESOMAR-certified market research organization and member of the Greater New York Chamber of Commerce) provides in-depth insights into the driving factors that increase demand in the market. It reveals opportunities that will drive market growth in various segments on the basis of source, application, sales channel, and end-use over the next 10 years.


Future Market Outlook Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Such. : +1-845-579-5705
For sales
LinkedIn|Twitter |Blogs

]]> RBI Policy Review Live Updates: RBI Set to Hike Policy Rates for Third Consecutive Time to Tame Inflation Fri, 05 Aug 2022 03:31:00 +0000

RBI Policy Review Live Updates: The Reserve Bank of India is expected to raise the policy rate by 25 to 50 basis points on Friday, the third hike since the start of the current fiscal year, to rein in the inflationary pressure.

Sixteen of 36 economists polled by Bloomberg see the Reserve Bank of India’s six-member monetary policy committee raise the repurchase rate by half a point to 5.40%, a level last seen in August 2019 Fourteen of them are calling for a 35 basis point hike, five for a quarter point stock and one for a 40 basis point increase – each of these moves being enough to bring the cost of borrowing back to the end of 2019 levels.

As Federal Reserve officials signal a pause is out of the question until they see evidence of slowing inflation, RBI watchers will be watching Governor Shaktikanta Das’ remarks closely. for any indication of the pace and duration of the monetary tightening cycle as it seeks to ensure a ‘soft landing’ for the economy. The central bank has raised the policy rate by 90 basis points since May, including a up half a point in June.

Following the trend, the Bank of England announced its biggest interest rate hike in 27 years on Thursday, predicting that the war in Ukraine would further fuel inflation and tip Britain’s economy into a prolonged recession.

!1 new updateClick here for the latest updates

Growth of services in India

India’s mainstream services industry growth hit a four-month low in July as inflationary pressures and falling demand limited gains in business activity, a private survey showed. The S&P Global India Services Purchasing Managers’ Index fell from 59.2 in June to 55.5 in July. The index slipped from an 11-month high in June and hit its lowest level since March.

“50bp rise in repo rate”

Data analytics firm CareEdge expects RBI to raise the key interest rate by another 100 basis points over the remainder of the 2022-23 financial year. This will take the terminal rate to 5.90% by the end of FY23. “We expect a 50 basis point hike in the repo rate in the next policy and another 50 basis point rate hike which will take the terminal repo rate to 5.90% by the end of the fiscal year,” said Rajani Sinha, Chief Economist, CareEdge.

Hiking trail

Even if the central bank slows rate hikes, economists believe that the maximum policy rate, or what is generally called the terminal rate, will be reached earlier in the cycle than expected. Barclays now sees the key rate rising to 5.50% by September from a previous mid-2023 forecast. This will signal that rates have reached neutral territory, said its India-based economist Rahul Bajoria, referring to a level where rates can help control inflation without stifling economic growth. It maintained its terminal rate projection at 5.75%.

Back to some indicators

  • Food prices rose 14.39% in June from a year ago
  • Fuel and electricity prices increased by 40.38%
  • Prices of manufactured goods increased slightly by 9.19%

Global central banks hike rates

‘Rates closer to 5.25%’

According to HDFC Bank Chief Economist Abheek Barua, the RBI is “likely to lift rates above a level deemed ‘neutral’ (which we believe is closer to 5.25%) before to slow down or consider becoming more data dependent in this rate hike cycle.”

FM Sitharaman on the economy and inflation

Earlier, Finance Minister Nirmala Sitharaman assured that the Indian economy, compared to the situation in many other peer groups and many developed economies, is definitely much better. On inflation, Sitharaman said the government and central bank had taken enough measures to keep inflation at 7% or ideally below 6%. The RBI has a mandate to target inflation within a range of 2-6%.

A look at wholesale inflation in India

India’s wholesale inflation eased from a three-decade high in June amid softer prices for global commodities, including crude and edible oils, which are key imports for the country. . Wholesale prices rose 15.18% in June from a year earlier, according to data released by the Ministry of Commerce.

Impact of the RBI decision on the stock markets

Srikanth Subramanian, CEO Designate of Kotak Cherry, said: “Equity markets appear to have priced in a 35 to 50 basis point rise and therefore a corresponding rate hike may not result in a large shock, particularly thanks to good profits and economic momentum.”

The Fed is expected to raise rates next month

Federal Reserve officials have expressed determination to contain high inflation, although it was noted that a half-percentage-point hike in the U.S. central bank’s key interest rate next month could be enough to make progress towards this goal. “I’m going from the idea that 50 (basis points) would be a reasonable thing to do in September because I believe I see evidence in my contact conversations, and in the observations of the world that I see, that there There are positives for me,” San Francisco Fed President Mary Daly said in an interview with Reuters.

Bank of England launches biggest interest rate hike in 27 years

The Bank of England announced its biggest interest rate hike in 27 years on Thursday, predicting that the war in Ukraine would further fuel inflation and tip Britain’s economy into a prolonged recession. Soaring natural gas prices are expected to push consumer price inflation to 13.3% in October from 9.4% in June, the bank said.

‘MPC will raise its benchmark repo rate by 50 basis points’

“We expect the RBI MPC to increase the benchmark repo rate by 50bps as the CPI continues to reign above the RBI threshold band. Commentary may be neutral/accommodative as the trend of the CPI appears to be tracking the RBI forecast for FY2023. Key to watch would also be the direction if in the future course of rate moves,” said Lakshmi Iyer, Chief Investment Officer (Debt) and Head of products, Kotak Mahindra Asset Management Company.” Whether or not to increase earlier this year, the key question for policymakers is how much to increase! The US Fed appears to be in a sprint when it comes to rate hikes. Most other economies may not have the luxury of a marathon race so,” Iyer said.

Markets seek abundant liquidity

Markets will also seek assurances from the RBI that there is sufficient liquidity and that the central bank is ready to implement measures to address any strains.

Raghuram Rajan on Rupee Worries

The central bank should remain focused on prices and not worry about the weak rupiah which is at a “nice level”, former RBI Governor Raghuram Rajan said in an interview with Bloomberg on Wednesday. “If you focus on controlling inflation, the exchange rate finds the appropriate level.”

The Rupee Tower

As the rupee hit a series of lows in recent months, falling from $80 to $1 in July, it retreated amid signs of a return in foreign fund inflows. Dovish signals from the monetary authority may not suit forex traders.

The pace and duration of the monetary tightening cycle

As Federal Reserve officials signal a pause is out of the question until they see evidence of slowing inflation, RBI watchers will be watching Governor Shaktikanta Das’ remarks closely. for any indication of the pace and duration of the monetary tightening cycle as it seeks to ensure a ‘soft landing’ for the economy. The central bank has raised the policy rate by 90 basis points since May, including a up half a point in June.

RBI’s fight against inflation

While inflation has remained above the RBI’s 6% target ceiling since the start of the year, falling commodity prices could give the central bank room to suggest pressures are easing .

RBI's fight against inflation

A change of posture?

India’s central bank-led rate-setting panel is most likely to raise the policy rate and perhaps change the dovish stance today as well.

Second repo policy rate hike

In its second bi-weekly monetary policy review in June, the RBI raised the repo rate by 50 basis points to 4.90%.

First increase in the rate of pensions on policy

In its off-cycle monetary policy review in May, the RBI raised the repo rate by 40 basis points or 0.40%. This was the first increase in the repo rate in nearly two years. The repo rate is the interest rate at which the RBI lends short-term funds to banks.

Third hike in a row

If the RBI chooses to raise the key repo rate today, it will be the third hike in a row. The RBI started to tighten its monetary policy at the beginning of the current financial year.

Magnitude of rate hike

While the rise in key interest rates is almost certain, analysts and economists have different opinions on the magnitude of the rate hike. It varies between 25 basis points and 50 basis points.

RBI Policy Review Today

The second bi-monthly meeting of the RBI’s monetary policy committee started on Wednesday. RBI Governor Shaktikanta Das is expected to announce the decisions of the monetary policy committee today.

Identity Theft Insurance Market Size, Share and Growth 2022-2029 | Key Players – Aura, Chubb, Experian Thu, 04 Aug 2022 07:17:33 +0000

Allied Market Research published a report titled “Identity Theft Insurance Market by Type (Credit Card Fraud, Employment or Tax Fraud, Telephone or Utilities Fraud, Bank Fraud and Others) and Application (Personal and Business): Global Opportunities Analysis and Industry Forecast, 2021-2030”.


The report offers an in-depth analysis of changing market dynamics, major investment pockets, major segments, value chain analysis, competitive landscape, and investment feasibility. The research offers a detailed analysis of drivers, restraints, and opportunities in the global Identity Theft Insurance Market. This information provides the guidance needed to determine the driving factors and implement strategies to achieve sustainable growth and exploit opportunities to explore market potential.

The research provides a comprehensive analysis of driving factors, restraining factors, and opportunities of the global Identity Theft Insurance Market. This analysis is helpful in identifying driving forces, achieving maximum growth, and adopting strategies to stay in the market. Additionally, investors, market players and new entrants can gain insights to explore the potential of the Identity Theft Insurance market, seize new opportunities and gain competitive advantage. A detailed elaboration of each factor is mentioned in the report to help market players in a deep understanding.

Scope of the report: –

Report attribute Details
Revenue forecasts in 2030 $2.09 billion
Rate of growth CAGR of 14.2% from 2021 to 2030
Forecast period 2021 to 2030
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, MEA
Country scope United States, Canada, Germany, United Kingdom, France, Italy, Spain, Japan, China, India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi Arabia
Profiled Key Companies Allstate Insurance Company, Aura, Chubb, Experian, GEICO, IdentityForce, Inc., IDShield, McAfee, LLC, NortonLifeLock Inc., and Nationwide Mutual Insurance Company Access the PDF table

Extended segmentation

• By type
o Credit card fraud
o Employment or tax fraud
o Fraud by telephone or public services
o Bank fraud
o Others

• By request
o Individuals
o Company

For the complete table of contents, see the [email protected]

An in-depth analysis of each segment and sub-segment is offered in the research in the form of graphs and tables. This analysis is helpful in determining the most revenue-generating and fastest-growing segments and implementing different strategies to achieve growth during the forecast period.

The research provides detailed competitive scenario of Global Identity Theft Insurance Market by region. Regional analysis in the report includes North America (United States, Mexico, and Canada), Europe (United Kingdom, Germany, France, Spain, Italy, and Rest of Europe), Asia-Pacific ( China, Japan, India, Australia and Rest of Asia-Pacific) and LAMEA (Latin America, Middle East and Africa). The aforementioned segments are analyzed for each region in the search. The data and statistics mentioned in the report provide valuable insights in determining the untapped potential of markets in different regions and adopting various strategies. AMR also offers customization services for particular regions and segments as per requirements.

For more information or query or customization before buying, visit @

Covid-19 impact analysis

  • Identity theft insurance market manufacturing activities have been halted due to lockdown measures taken in many countries. Additionally, supply chain disruptions and shortage of raw materials have created difficulties in carrying out manufacturing at full capacity.
  • Demand from end-use industries has dropped significantly due to the shutdown of day-to-day operations during the lockdown. However, demand would steadily increase during post-lockdown as daily operations resume.
  • The ban on import-export activities has led to supply chain disruption and a gap between supply and demand. As restrictions are lifted, the supply chain will be restored.

The report offers a detailed scenario of the global identity theft insurance market during the Covid-19 pandemic. This information is useful for market participants, investors, startups and others to revise their strategies and minimize the impact on their business. The impact mentioned in the report is the result of extensive research.

Competitive landscape

The report offers a detailed analysis of key market players operating in the global Identity Theft Insurance Market. Major market players profiled in the report are Allstate Insurance Company, Aura, Chubb, Experian, GEICO, IdentityForce, Inc., IDShield, McAfee, LLC, NortonLifeLock Inc., and Nationwide Mutual Insurance Company. The competitive landscape and strategies adopted by market players are mentioned in the report. These Identity Theft Insurance market players have adopted various strategies such as new product launches, partnerships, joint ventures, collaborations, mergers and acquisitions, expansion and others to enjoy a sustainable growth and strengthen their presence in the global identity theft insurance market.

Request before purchase @

About Us

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unparalleled quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

Pawan Kumar, CEO of Allied Market Research, leads the organization in delivering high quality data and insights. We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. All data presented in the reports we publish are drawn from primary interviews with senior managers of large companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.

Contact us

David Correa

Portland, OR, USA

USA/Canada (toll-free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

[email protected]


Follow us on LinkedIn:

IBD stock of the day; PBR Stock Eyes New Buy Point on Strong Petrobas Earnings and Huge Dividend Wed, 03 Aug 2022 18:03:00 +0000







Analysis of MICI stocks

  • Close to 14.98 base cup buy point, but may soon get a handful
  • Profits soared 1,273% in 2021, with strong growth this year
  • Dividend yield exceeds 44%

composite score

Industry group ranking

Emerging model


* No real-time data. All data displayed was captured at 1:53 p.m. EDT on 08/03/2022.

Brazilian oil giant Petrobras is the IBD stock of the day, with PBR stock working a handle buy point as earnings rise amid high oil prices. The oil stock also offers a juicy, if controversial, dividend.

Petrobras (PBR) produces 1,852,000 barrels of petroleum products per day. It has 5,042 oil and gas wells, 123 owned and chartered vessels and 12 refineries.

Founded in 1953, the company is based in Rio de Janeiro. The main world markets are Brazil (73% of turnover), the United States (6.6%) and China (4.9%).

Rivals include Chevron (CLC), Exxon Mobil (XOM) and Shell (SHEL). They also include Saudi oil.

Many energy stocks are on the powerful IBD Leaderboard and IBD 50 list of the most important growth stocks. These include XOM stock and New Fortress Energy (ENF). Several are creating or considering new entries.

But energy stocks oscillate with energy prices. Crude oil prices are far from their June highs, dropping significantly on Wednesday. US natural gas prices are still near long-term highs, with European natural gas prices extremely high.

IBD Live: a new daily stock market analysis tool

PBR Stock Eyes Bottom Handle Entry

Shares of Petrobras were up 1 cent at 13.85 trading today, after falling slightly in the previous two sessions. The PBR stock is well above the 50-day moving average.

After rallying 22.7% last week, PBR stock formed the right side of a cut base with a buy point of 14.98. With this week’s decline, the oil stock is working on a possible handle, which would reduce the buy point to 14.54.

A decent handful, which won’t be valid until Friday’s close. would be a positive technical sign. It would also let the 50-day line for the PBR stock catch up a bit.

The relative strength line for PBR stocks has soared in the first half of this year, according to chart analysis from MarketSmith. It dipped in June but is nearly back near its May peak, albeit below all-time highs. A rising RS line is a sign of outperformance against the S&P 500.

The pattern includes an earnings gap of nearly 7% on July 29. It dates back to the end of May and follows a successful breakout in December.

A relative strength rating of 98 means that Petrobras has outperformed 99% of all stocks in IBD’s database over the past year.

The integrated oil and gas industry group is doing well, ranked No. 31 out of 197 groups tracked by IBD. The PBR stock is the #1 stock out of 22 stocks in this group.

Petrobras profits will jump 74%

Petrobras achieves a perfect IBD composite score of 99, the highest in its group. Comp Scoring combines key fundamental and technical metrics into one easy-to-use score.

An EPS rating of 77 reflects its earnings return after declines. Petrobras shows zero quarter of earnings acceleration but one quarter of sales acceleration.

On July 28, Petrobras broke earnings estimates for the June quarter.

Additionally, Petrobras generated free cash flow of $12.8 billion, up 61% from the prior quarter. Sales were also up 28% from the first quarter “mainly due to a 12% rise in Brent prices, higher oil and petroleum product sales volumes and higher petroleum product prices. and natural gas,” the company said in its earnings release.

Petrobras linked the sales gain to the recovery in global demand for oil and petroleum products after the Covid-19 pandemic. In addition, the war in Ukraine has had a negative impact on supplies, he added.

In 2021, Petrobras earnings rebounded 1,273% to $3.17 per share. They sank 81% the previous year. The pandemic has crushed energy demand.

Wall Street analysts expect ACB profits to rise 74% for all of 2022, while revenues rise 32%. They expect profits and sales to fall in 2023.

Of 13 Wall Street analysts, seven are evaluating the PBR stock buy and six have a grip. No one has sales, shows FactSet.

Their average target price of $16.76 implies an additional 21% upside for PBR stock following its post-earnings surge. Four analysts raised their price targets on Petrobras after its July 28 earnings overshoot, and one cut.

Alongside Petrobras, Exxon Mobil and Chevron beat second-quarter results on July 29, posting record profits.

Funds pile up in oil stock but challenges persist

According to the IBD Stock Checkup tool, the oil stock shows four quarters of increases in fund ownership. In June, 479 funds held PBR shares, up 2% from March.

Funds holding Petrobras shares include the highly rated Fidelity Contrafund.

However, the state-controlled PBR is subject to political whims. Brazil’s government, with a majority stake and facing a tough re-election battle later this year, asked Petrobras in July to raise dividends, Reuters said.

Petrobras will therefore hand out at least twice as much as its biggest international rivals in Q2 dividends, swelling government coffers.

It will also distribute around 60% more to shareholders than its $10.5 billion (54.33 billion reais) profit. Critics claim the huge payout will lead to underinvestment in the business.

Year-to-date, PBR stock has gained 50.6%. It gives 44.5%.


These are the 5 best stocks to buy and watch right now

Stocks to watch: IPOs, large caps and top-rated growth stocks

Find the latest stocks reaching buy zones with MarketSmith

Why This IBD Tool Simplifies Finding Best Stocks

Looking for the next big winners in the stock market? Start with these 3 steps